SnapCyte Solutions Inc. Announces Closing of Financing Round
October 3, 2022 | Vancouver, British Columbia | Public Announcement – SnapCyte Solutions Inc., a bio-analytical software company committed to advancing artificial intelligence (AI)-powered smartphone technology for biological and life science research, has closed a financing agreement with a Canadian investment company.
SnapCyte Solutions Inc. is developing laboratory smartphone technology for instant, accurate, and intelligent assessment of cell culture confluency and fitness in real-time. The technology is based on an AI algorithm that enables the SnapCyte™ app to increase performance and accuracy over time.
“With this agreement, we have found a financial partner that shares our vision of democratizing research by providing easy-to-access, intelligent and accurate smartphone tools to research laboratories around the world”, says Dr. Mads Daugaard, CEO of SnapCyte Solutions Inc. “This investment will allow SnapCyte Solutions Inc. to introduce the SnapCyte™ app on the global market and initiate development of new product lines”.
The first iteration of the SnapCyte™ app will become available to the world-wide research community on iOS and Android in 2023.
About SnapCyte Solutions Inc.
SnapCyte Solutions Inc. is a privately held company incorporated in British Columbia, Canada. The company develops and distributes AI-based smartphone applications for assessment of cell line culture growth and fitness in biology and life science research. The company is also engaged in the development and distribution of microscope adapters for mounting smartphones to microscopes.
